Thrombotic Thrombocytopenic Purpura in Interferon Beta-1a-Treated Patient Diagnosed with Relapsing-Remitting Multiple Sclerosis: A Case Report

Background: Secondary thrombotic thrombocytopenic purpura (TTP) due to interferon beta-1a intramuscular (im) treatment is an uncommon adverse effect with only a few cases in multiple sclerosis patients reported worldwide. TTP together with haemolytic uremic syndrome (HUS) are classic forms of thromb...

Descripción completa

Detalles Bibliográficos
Autores principales: Plesa, Cristina-Florentina, Chitimus, Diana Maria, Sirbu, Carmen Adella, Țânțu, Monica Marilena, Ghinescu, Minerva Claudia, Anghel, Daniela, Ionita-Radu, Florentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778067/
https://www.ncbi.nlm.nih.gov/pubmed/35054473
http://dx.doi.org/10.3390/life12010080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778067/
https://www.ncbi.nlm.nih.gov/pubmed/35054473
http://dx.doi.org/10.3390/life12010080

Ejemplares similares